Kuala Lumpur: Pharmaniaga bhd announced. That they will be supplying the Sinovac covid-19 vaccine to the state governments and private sector. As a result, their share surged on Wednesday. The share achieved an intra-day high of RM5.54 before ending the day RM5.34.
The company’s shareholders announced a statement in a meeting held virtually. Their drive was to supplement the government push to accomplish immunity for the local citizen. And to recover the staggering economy of the nation at a quicker speed. Datuk Zulkarnain Md Eusope, the Group managing director, said that the central focus is on the financial frontline. Among the government-linked companies(GLCs), private firms, foreign specialists, and experts in the country.
In his statement, he also added that “We shall also offer the vaccines to the state governments. That wish to expedite their own Covid-19 immunization programs. We will ensure an effective provision and distribution of the Sinovac Covid-19 vaccine doses. Supply to the private market and state governments. And it will not disrupt our existing contractual obligation with the Federal Government.”
Pharmaniaga company has set a priority to finish it’s authoritative commitment of providing 12 million doses of Sinovac Covid-19 vaccine to the federal government by July. Which will be adequate to cover approx 18% of the country’s populace. To the company’s decision to supply the Sinovac Covid-19 vaccine to the state governments and private sector. Zulkarnain said that this expansion in the market likewise denotes a solid repositioning that will fortify the company’s traction in the private market. He additionally brought up the vaccination which was recently endorsed by the World Health Organization (WHO). And the acknowledgment is an increase in trust in the fight against the pandemic.
He also said that Pharmaniaga will present the applicable reports to NPRA for variety measure. “Upon obtaining the approval, we will be able to ramp up our capacity from two million to four million doses a month, ” he added. Datuk Seri Mohammed Shazalli Ramly, Pharmaniaga manager, said the company has substantiated in tough years with questionable monetary circumstances. While reacting quickly to the pandemic episode and upheld all the Government’s endeavors in securing the country and rakyat. The company intends to speed up the development of the Halal vaccine fabricating business with different kinds of antibody improvement projects.
The statement issued by the company is as follows – “Our plans to establish the world’s first Halal vaccine facility are progressing well, in close collaboration with Malaysian Investment Development Authority (MIDA) and Halal Development Corporation Berhad (HDC). The Halal vaccine project has been selected as a pioneering initiative for policy and incentive development purposes.
The facility is targeted to start operating in 2024 and aims to create a new revenue stream for the group while generating multiple positive spills over benefits, including improving our nation’s pandemic preparedness towards cultivating a sustainable vaccine supply chain. In addition, it will provide opportunities for upskilling local talent whilst increasing access to affordable vaccines for both local and international markets. This will subsequently position Malaysia as a global vaccine manufacturer.”
